News
New malaria drug requires just one dose and appears twice as effective as existing regimen
Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine against this global scourge and may fight off the disease with one dose, instead of...
News
Cold viruses point the way to new cancer therapies
Cold viruses generally get a bad rap - which they've certainly earned - but new findings by a team of scientists at the Salk Institute for Biological Studies suggest that these viruses might also be a valuable ally...
News
Target for obesity drugs comes into focus
Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain. Leptin is a hormone secreted by fat...
News
Strategies proposed to improve impact of comparative effectiveness studies
Comparative effectiveness research conducted over the past decade has had a limited impact on the way medical care is delivered, but many opportunities exist to help doctors and others in the medical system translate such research into better...
News
UCB announces third research collaboration with Harvard University
UCB announced that it has launched a third collaborative research project with Harvard that builds upon the innovative Research Alliance they both signed in 2011. The third research project named 'Mining the Human Microbiome' will...
News
RNA-based therapy brings new hope for an incurable blood cancer
Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma...
News
Rare disease researchers notch a win for patients with inherited muscle disease
An older medication originally approved to treat heart problems eases the symptoms of a very rare muscle disease that often leaves its sufferers stiff and in a good deal of pain, physicians and researchers report in the Journal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read